StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Precision BioSciences's ebitda for the twelve months ending Jun 30, 2026 was -$35.15M. For fiscal 2025 it was -$50.68M. The highest annual figure on record is -$22.76M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.68M–
FY2024Dec 31, 2024-$22.76M–
FY2023Dec 31, 2023-$36.92M–
FY2022Dec 31, 2022-$54.51M–
FY2021Dec 31, 2021-$30.40M–
FY2020Dec 31, 2020-$101.05M–
FY2019Dec 31, 2019-$81.89M–
FY2018Dec 31, 2018-$45.56M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.91M–
Q1 FY2026Mar 31, 2026-$8.78M–
Q4 FY2025Dec 31, 2025$12.85M–
Q3 FY2025Sep 30, 2025-$20.32M–
Q2 FY2025Jun 30, 2025-$21.50M-185.2%
Q1 FY2025Mar 31, 2025-$21.72M–
Q4 FY2024Dec 31, 2024-$24.39M–
Q3 FY2024Sep 30, 2024-$20.56M–
Q2 FY2024Jun 30, 2024$25.24M–
Q1 FY2024Mar 31, 2024-$3.04M–
Q4 FY2023Dec 31, 2023-$13.61M–
Q3 FY2023Sep 30, 2023-$10.74M–
Q2 FY2023Jun 30, 2023-$1.16M–
Q1 FY2023Mar 31, 2023-$11.40M–
Q4 FY2022Dec 31, 2022-$10.15M–
Q3 FY2022Sep 30, 2022-$12.74M–
Q2 FY2022Jun 30, 2022-$27.63M-215.1%
Q1 FY2022Mar 31, 2022-$25.37M–
Q4 FY2021Dec 31, 2021-$28.55M–
Q3 FY2021Sep 30, 2021-$9.28M–
Q2 FY2021Jun 30, 2021$24.00M–
Q1 FY2021Mar 31, 2021-$16.57M–
Q4 FY2020Dec 31, 2020-$21.29M–
Q3 FY2020Sep 30, 2020-$23.82M–
Q2 FY2020Jun 30, 2020-$30.61M–
Q1 FY2020Mar 31, 2020-$25.34M–
Q4 FY2019Dec 31, 2019-$20.05M–
Q3 FY2019Sep 30, 2019-$20.58M–
Q2 FY2019Jun 30, 2019-$22.70M–
Q1 FY2019Mar 31, 2019-$18.56M–
Q4 FY2018Dec 31, 2018-$15.31M–
Q3 FY2018Sep 30, 2018-$9.86M–
Q2 FY2018Jun 30, 2018-$11.61M–
Q1 FY2018Mar 31, 2018-$8.78M–

More Precision BioSciences figures

See a number that looks wrong?